NACB SERIES: LABORATORY MEDICINE PRACTICE GUIDELINES
Series formerly called: Standards of Laboratory Practice

Guidelines & Recommendations for Laboratory Analysis in the Diagnosis & Management of Diabetes Mellitus

Recommendations will be presented by an expert panel on the use of laboratory analytes for the diagnosis and management of patients with diabetes mellitus – Presented as an Edutrak session at the AACC’s 52nd Annual Meeting in San Francisco, July 23 –27, 2000.

Please note that the first draft of the guidelines now appears on this web site for your response and commentary in June 30, 2000.

Program Chair
David Sacks, M.B., Ch.B.
dsacks@rics.bwh.harvard.edu

3305 Guidelines & Recommendations for Laboratory Analysis in the Diagnosis & Management of Diabetes Mellitus

Moderator: David Sacks, MB, ChB, Harvard Medical School & Brigham & Women's Hospital, Boston, MA
Developed in cooperation with the National Association for Clinical Biochemistry
Level: Intermediate
CE Credit Hours: 1.5 (morning); 2.25 (afternoon)

Intended Audience: This session is targeted to clinical pathologists, clinical chemists, clinical laboratory scientists, laboratory managers, laboratory technologists, and trainees in laboratory medicine.
Overview: It is estimated that more than 15 million Americans have diabetes mellitus. The multiple cardiovascular, retinal, and renal complications that result cause annual health care costs in excess of $92 billion. This session will provide a critical evaluation of the analytes used in diagnosing and monitoring diabetes, both type 1 and type 2. Recommended guidelines will be outlined for antibodies, glucose, ketones, glycated proteins, urinary albumin excretion, insulin, and other pertinent analytes. Whenever possible, evidence-based guidelines will be presented. Adequate time will be available for comments from the audience on the proposed recommendations for developing clinically useful guidelines.
Expected Outcomes: At the conclusion of this session, participants will be able to 1) identify analytes that are clinically useful in the management of patients with diabetes; 2) understand the role of antibodies in current practice in diabetes; 3) comprehend the issues related to glucose meters; 4) recognize the problems associated with Hb A1c; and 5) be aware of emerging considerations currently used in research.

Morning Session

Immunologic & Genetic Testing in Diabetes
 Noel Maclaren, MD, Weill College of Medicine of Cornell Univ., Ithaca, NY

The Role of Glucose Measurement in Diabetes
David B. Sacks, MB, ChB

Afternoon Session

Non- & Minimally-Invasive Glucose Analysis
Jay M. McDonald, MD, Univ. of Alabama, Birmingham

Monitoring of Patients with Diabetes: Ketone & Glycated Protein Testing
David Goldstein, MD, Univ. of Missouri, Columbia

Insulin & Precursors, Leptin & Amylin: Is There a Role?
Marion Parrott, MD, American Diabetes Association, Alexandria, VA

Testing for Microalbuminuria
David Bruns, MD, Univ. of Virginia Medical Center, Charlottesville